{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:46:40Z","timestamp":1793605600986,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.jaci.2009.08.046","type":"journal-article","created":{"date-parts":[[2009,11,5]],"date-time":"2009-11-05T07:33:33Z","timestamp":1257406413000},"page":"1022-1030.e395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":261,"title":["Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes"],"prefix":"10.1016","volume":"124","author":[{"given":"Lisa C.","family":"Zaba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayte","family":"Su\u00e1rez-Fari\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judilyn","family":"Fuentes-Duculan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine E.","family":"Nograles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Guttman-Yassky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Cardinale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Lowes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2009.08.046_bib1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1073\/pnas.73.2.381","article-title":"Partial purification of a serum factor that causes necrosis of tumors","volume":"73","author":"Green","year":"1976","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2009.08.046_bib2","first-page":"255","article-title":"The effects of tumor necrosis factor on the production of interleukin-1 by macrophages","volume":"5","author":"Hoffman","year":"1986","journal-title":"Lymphokine Res"},{"key":"10.1016\/j.jaci.2009.08.046_bib3","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1128\/iai.32.3.1058-1066.1981","article-title":"Possible importance of macrophage-derived mediators in acute malaria","volume":"32","author":"Clark","year":"1981","journal-title":"Infect Immun"},{"key":"10.1016\/j.jaci.2009.08.046_bib4","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1016\/j.jaad.2005.10.059","article-title":"What have we learned in dermatology from the biologic therapies?","volume":"54","author":"Nickoloff","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2009.08.046_bib5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/ard.58.6.350","article-title":"Increased vulnerability of postarthritic cartilage to a second arthritic insult: accelerated MMP activity in a flare up of arthritis","volume":"58","author":"van Meurs","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2009.08.046_bib6","doi-asserted-by":"crossref","DOI":"10.1186\/ar2419","article-title":"Molecular discrimination of responders and nonresponders to anti-TNF alpha therapy in rheumatoid arthritis by etanercept","volume":"10","author":"Koczan","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaci.2009.08.046_bib7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1396-0296.2004.04043.x","article-title":"Etanercept for the treatment of psoriasis and psoriatic arthritis","volume":"17","author":"Gottlieb","year":"2004","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaci.2009.08.046_bib8","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s11894-006-0041-5","article-title":"Advances in biologic therapy for ulcerative colitis and Crohn's disease","volume":"8","author":"D'Haens","year":"2006","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.jaci.2009.08.046_bib9","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.4049\/jimmunol.176.11.7104","article-title":"Identical TCR beta-chain rearrangements in streptococcal angina and skin lesions of patients with psoriasis vulgaris","volume":"176","author":"Diluvio","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2009.08.046_bib10","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1001\/archderm.1997.03890420031004","article-title":"Persistence of T-cell clones in psoriatic lesions","volume":"133","author":"Chang","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2009.08.046_bib11","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/eji.1830240315","article-title":"T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products","volume":"24","author":"Prinz","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2009.08.046_bib12","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/S0190-9622(89)80200-2","article-title":"Remission of psoriatic lesions with muromonab-CD3 (orthoclone OKT3) treatment","volume":"20","author":"Weinshenker","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2009.08.046_bib13","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nm0595-442","article-title":"Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis","volume":"1","author":"Gottlieb","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2009.08.046_bib14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/3-540-26811-1_11","article-title":"From classical mouse models of psoriasis to a spontaneous xenograft model featuring use of AGR mice","volume":"50","author":"Nestle","year":"2005","journal-title":"Ernst Schering Res Found Workshop"},{"key":"10.1016\/j.jaci.2009.08.046_bib15","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa062382","article-title":"A human interleukin-12\/23 monoclonal antibody for the treatment of psoriasis","volume":"356","author":"Krueger","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2009.08.046_bib16","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1185\/030079907X182112","article-title":"A phase 1, double-blind, placebo-controlled study evaluating single subcutaneous administrations of a human interleukin-12\/23 monoclonal antibody in subjects with plaque psoriasis","volume":"23","author":"Gottlieb","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaci.2009.08.046_bib17","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1172\/JCI21404","article-title":"IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6","volume":"116","author":"Yen","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2009.08.046_bib18","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.4049\/jimmunol.177.7.4917","article-title":"An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12\/IL-23 in psoriasis","volume":"177","author":"Toichi","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2009.08.046_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.it.2005.10.003","article-title":"Understanding the IL-23-IL-17 immune pathway","volume":"27","author":"McKenzie","year":"2006","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaci.2009.08.046_bib20","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1084\/jem.20071094","article-title":"Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses","volume":"204","author":"Zaba","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2009.08.046_bib21","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.4049\/jimmunol.180.3.1913","article-title":"Identification of cellular pathways of \"type 1,\" Th17 T cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A in psoriasis","volume":"180","author":"Haider","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2009.08.046_bib22","first-page":"1092","article-title":"Th17 cytokines IL-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways","volume":"159","author":"Nograles","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2009.08.046_bib23","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2009.08.046_bib24","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.jaci.2008.02.026","article-title":"The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29","volume":"121","author":"Commins","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.08.046_bib25","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.1073\/pnas.0400782101","article-title":"A gene atlas of the mouse and human protein-encoding transcriptomes","volume":"101","author":"Su","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2009.08.046_bib26","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s10753-006-9004-0","article-title":"Circulating levels of urokinase-type plasminogen activator (uPA) and its soluble receptor (suPAR) in patients with atopic eczema\/dermatitis syndrome","volume":"29","author":"Kasperska-Zajac","year":"2005","journal-title":"Inflammation"},{"key":"10.1016\/j.jaci.2009.08.046_bib27","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1172\/JCI32282","article-title":"Normal human dermis contains distinct populations of CD11c + BDCA-1+ dendritic cells and CD163 + FXIIIA+ macrophages","volume":"117","author":"Zaba","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2009.08.046_bib28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/jid.2008.194","article-title":"Psoriasis is characterized by accumulation of immunostimulatory and Th1\/Th17 cell-polarizing myeloid dendritic cells","volume":"129","author":"Zaba","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2009.08.046_bib29","doi-asserted-by":"crossref","first-page":"8391","DOI":"10.4049\/jimmunol.181.12.8391","article-title":"CCR6 regulates the migration of inflammatory and regulatory T cells","volume":"181","author":"Yamazaki","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2009.08.046_bib30","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1001\/archderm.140.2.218","article-title":"Potential of tumor necrosis factor inhibitors in psoriasis and psoriatic arthritis","volume":"140","author":"Krueger","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2009.08.046_bib31","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/sj.jid.5701255","article-title":"Polymorphisms of the IL12B and IL23R genes are associated with psoriasis","volume":"128","author":"Nair","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2009.08.046_bib32","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0140-6736(08)60726-6","article-title":"Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)","volume":"371","author":"Papp","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2009.08.046_bib33","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.4049\/jimmunol.171.5.2262","article-title":"TNF skews monocyte differentiation from macrophages to dendritic cells","volume":"171","author":"Chomarat","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2009.08.046_bib34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/cr.2009.26","article-title":"More stories on Th17 cells","volume":"19","author":"Basso","year":"2009","journal-title":"Cell Res"},{"key":"10.1016\/j.jaci.2009.08.046_bib35","doi-asserted-by":"crossref","DOI":"10.1189\/JLB.0109046","article-title":"IL-17-producing CD8 + T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines","author":"Ortega","year":"2009","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2009.08.046_bib36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/jid.2008.194","article-title":"Psoriasis is characterized by accumulation of immunostimulatory and Th1\/Th17 cell-polarizing myeloid dendritic cells","volume":"129","author":"Zaba","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2009.08.046_bib37","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/1471-2105-6-294","article-title":"Harshlight: a \u201ccorrective make-up\u201d program for microarray chips","volume":"6","author":"Suarez-Farinas","year":"2005","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jaci.2009.08.046_bib38","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/bioinformatics\/19.1.155","article-title":"An extensible application for assembling annotation for genomic data","volume":"19","author":"Zhang","year":"2003","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jaci.2009.08.046_bib39","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ng0506-500","article-title":"GenePattern 2.0","volume":"38","author":"Reich","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2009.08.046_bib40","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167490901330X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167490901330X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:17:44Z","timestamp":1758788264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009167490901330X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S009167490901330X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2009.08.046","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2009.08.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}